A detailed history of Alliancebernstein L.P. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,476 shares of BGNE stock, worth $212,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,476
Previous 10,229 85.57%
Holding current value
$212,440
Previous $1.84 Million 87.53%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$141.8 - $181.47 $1.24 Million - $1.59 Million
-8,753 Reduced 85.57%
1,476 $230,000
Q4 2023

Feb 14, 2024

BUY
$158.67 - $201.58 $1.05 Million - $1.33 Million
6,600 Added 181.87%
10,229 $1.84 Million
Q3 2023

Nov 14, 2023

BUY
$179.87 - $225.13 $216,743 - $271,281
1,205 Added 49.71%
3,629 $652,000
Q2 2023

Aug 15, 2023

BUY
$178.3 - $266.78 $432,199 - $646,674
2,424 New
2,424 $432,000
Q2 2022

Aug 15, 2022

SELL
$121.11 - $216.05 $1.89 Million - $3.37 Million
-15,584 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$146.52 - $269.56 $1.54 Million - $2.82 Million
10,477 Added 205.15%
15,584 $2.94 Million
Q4 2021

Feb 14, 2022

BUY
$248.56 - $389.34 $1.27 Million - $1.99 Million
5,107 New
5,107 $1.38 Million
Q3 2021

Nov 10, 2021

SELL
$249.6 - $403.14 $407,846 - $658,730
-1,634 Closed
0 $0
Q2 2021

Jul 30, 2021

BUY
$292.75 - $367.01 $478,353 - $599,694
1,634 New
1,634 $561,000
Q1 2021

May 06, 2021

SELL
$260.64 - $382.12 $210,597 - $308,752
-808 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$221.31 - $316.61 $28 Million - $40.1 Million
-126,658 Reduced 99.37%
808 $209,000
Q3 2020

Nov 12, 2020

SELL
$189.18 - $286.44 $34 Million - $51.5 Million
-179,681 Reduced 58.5%
127,466 $36.5 Million
Q2 2020

Aug 13, 2020

BUY
$123.9 - $195.41 $490,520 - $773,628
3,959 Added 1.31%
307,147 $57.9 Million
Q1 2020

May 14, 2020

SELL
$121.84 - $173.19 $215,291 - $306,026
-1,767 Reduced 0.58%
303,188 $37.3 Million
Q4 2019

Feb 18, 2020

SELL
$115.78 - $208.34 $12.8 Million - $22.9 Million
-110,134 Reduced 26.53%
304,955 $50.5 Million
Q3 2019

Nov 14, 2019

BUY
$120.61 - $148.29 $3.02 Million - $3.71 Million
25,015 Added 6.41%
415,089 $50.8 Million
Q2 2019

Aug 14, 2019

BUY
$113.99 - $146.86 $155,140 - $199,876
1,361 Added 0.35%
390,074 $48.4 Million
Q1 2019

May 14, 2019

BUY
$122.82 - $151.83 $1.38 Million - $1.71 Million
11,267 Added 2.99%
388,713 $51.3 Million
Q4 2018

Feb 13, 2019

BUY
$107.01 - $175.15 $10.5 Million - $17.2 Million
98,116 Added 35.13%
377,446 $52.9 Million
Q3 2018

Nov 08, 2018

BUY
$152.62 - $189.66 $5.3 Million - $6.59 Million
34,750 Added 14.21%
279,330 $48.1 Million
Q2 2018

Aug 13, 2018

SELL
$152.5 - $216.77 $1.14 Million - $1.61 Million
-7,444 Reduced 2.95%
244,580 $37.6 Million
Q1 2018

May 14, 2018

SELL
$97.41 - $177.22 $17.5 Million - $31.9 Million
-179,850 Reduced 41.64%
252,024 $42.3 Million
Q4 2017

Feb 13, 2018

SELL
$79.6 - $114.73 $5.39 Million - $7.77 Million
-67,682 Reduced 13.55%
431,874 $42.2 Million
Q3 2017

Nov 13, 2017

BUY
$66.19 - $103.46 $33.1 Million - $51.7 Million
499,556
499,556 $51.7 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $14.9B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.